Showing results (11-20 of 201) with videos related to
Sort By:
Pageof 21
Drug Discovery Today. Technologies|November 21, 2012
NMR in the Analysis of Functional Chemokine Interactions and Drug DiscoveryJoshua J Ziarek, Brian F VolkmanMolecular Pharmacology|July 22, 2025
Progress toward new function and design of extracellular G protein-coupled receptor nanobodiesRoman R Schlimgen, Brian F VolkmanTrends in Biochemical Sciences|June 3, 2023
Metamorphic protein folding as evolutionary adaptationAcacia F Dishman, Brian F VolkmanFrontiers in Immunology|April 3, 2023
Prospects for targeting ACKR1 in cancer and other diseasesKyler S Crawford, Brian F VolkmanThe Journal of Physical Chemistry. B|July 3, 2015
Interplay of Electrostatics and Hydrophobic Effects in the Metamorphic Protein Human LymphotactinElif Nihal Korkmaz, Brian F Volkman, Qiang CuiArchives of Biochemistry and Biophysics|March 13, 2002
Refined structure and metal binding site of the kalata B1 peptideLars Skjeldal, Lorents Gran, Knut Sletten, et al.Methods in Enzymology|June 2, 2009
Chapter 3. Lymphotactin structural dynamicsBrian F Volkman, Tina Y Liu, Francis C PetersonBiopolymers|September 28, 2020
Specific binding-induced modulation of the XCL1 metamorphic equilibriumAcacia F Dishman, Francis C Peterson, Brian F VolkmanJournal of Leukocyte Biology|February 4, 2025
Extended repertoire of CXC chemokines acting as agonists and antagonists of the human and murine atypical chemokine receptor ACKR2Rafael Luís, Brian F Volkman, Martyna Szpakowska, et al.Journal of Leukocyte Biology|June 7, 2018
Decoding the chemotactic signalMonica A Thomas, Andrew B Kleist, Brian F VolkmanPageof 21